Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
US7569554B2 · kind B2 · utility
15Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2004 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | May 6, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the therapeutic use of immunostimulatory oligonucleotides and/or immunomers in combination with chemotherapeutic agents to provide a synergistic therapeutic effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.